{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T22:41:05Z","timestamp":1784846465957,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jbspin.2011.10.001","type":"journal-article","created":{"date-parts":[[2011,11,16]],"date-time":"2011-11-16T11:30:38Z","timestamp":1321443038000},"page":"457-463","source":"Crossref","is-referenced-by-count":103,"title":["Development of inflammatory bowel disease during anti-TNF-\u03b1 therapy for inflammatory rheumatic disease. A nationwide series"],"prefix":"10.1016","volume":"79","author":[{"given":"\u00c9ric","family":"Toussirot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9ric","family":"Houvenagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Go\u00ebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Fouache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Le Dantec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Dernis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wendling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiphaine","family":"Ansemant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Berthelot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Bader-Meunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Kantelip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2011.10.001_bib0005","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized double blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0010","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/rheumatology\/kep083","article-title":"Paradoxical adverse events of anti-tumour necrosis factor therapy for spondylarthropathies: a retrospective study","volume":"48","author":"Fouache","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0015","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/rheumatology\/kep046","article-title":"Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases","volume":"48","author":"Immediato-Dai\u00ebn","year":"2009","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0020","series-title":"Biopsy interpretation of the gastrointestinal tract","first-page":"213","article-title":"Colon inflammatory","author":"Montgommery","year":"2005"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0025","first-page":"752","article-title":"Development of Crohn's disease in a patient taking etanercept","volume":"32","author":"Oh","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2133.2007.08009.x","article-title":"Development of Crohn's disease in a patient on etanercept for psoriasis","volume":"157","author":"Ahmad","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0035","first-page":"532","article-title":"New onset of Crohn's disease during treatment of active ankylosing spondylitis with etanercept","volume":"35","author":"Song","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0040","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1080\/00365520601106228","article-title":"First appearance of Crohn's disease following infliximab treatment for spondylarthropathy","volume":"42","author":"Tsochatzis","year":"2007","journal-title":"Scand J Gastrenterol"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0045","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1463-1318.2008.01490.x","article-title":"Developemnt of Crohn's disease following anti-tumour necrosis factor therapy (etanercept)","volume":"10","author":"Yazisiz","year":"2008","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0050","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2174\/1874312900802010053","article-title":"The changing face of spondylarthropathies under TNF-\u03b1 blockade","volume":"2","author":"Elkayam","year":"2008","journal-title":"Open Rheumatol J"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0055","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semarthrit.2008.06.004","article-title":"Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action","volume":"39","author":"Haraoui","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0060","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005176-200408000-00016","article-title":"Development of Crohn's disease during anti TNF-\u03b1 therapy in a child with juvenile idiopathic arthritis","volume":"39","author":"Ruemmele","year":"2004","journal-title":"J Ped Gastroenterol Nutr"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0065","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00296-009-0991-7","article-title":"Crohn's disease during etanercept therapy in juvenile idiopathic arthritis: a case report and review of the literature","volume":"30","author":"Wiegering","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0070","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/rheumatology\/keq136","article-title":"Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study","volume":"49","author":"Dallochio","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0075","first-page":"342","article-title":"Emergence of Crohn's disease in juvenile idiopathic arthritis during treatment of etanercept: a causal link or a mere coincidence?","volume":"19","author":"Oikonomou","year":"2010","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0080","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1002\/art.11325","article-title":"Recombinant human tumor necrosis factor receptor (etanercept) fro treating ankylosing spondylitis. A randomized controlled trial","volume":"48","author":"Davis","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0085","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/rheumatology\/keh475","article-title":"Long-term efficacy and safety of etanercept after readministration in patients with active ankylosing spondylitis","volume":"44","author":"Brandt","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0090","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MAJ.0b013e3180312362","article-title":"Tumor necrosis factor alpha inhibitor associated ulcerative colitis","volume":"333","author":"Prescott","year":"2007","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0095","first-page":"2279","article-title":"The evolution of spondylarthropathies in relation to gut histology. III. Relation between gut and joint","volume":"22","author":"Mielants","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0100","first-page":"307","article-title":"Crohn's disease associated with seropositive rheumatoid arthritis","volume":"15","author":"Toussirot","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0105","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/art.22669","article-title":"Differences in the incidence of flares or new onset of inflammatory bowel diseases in patients with ankylosing spondylitis exposed to therapy with anti-tumor necrosis factor \u03b1 agents","volume":"57","author":"Braun","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0110","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2007.069484","article-title":"Focus on adverse events of tumor necrosis factor a blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients","volume":"67","author":"Gerloni","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0115","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.62.1.74","article-title":"Efficacy of etanercept for the treatment of Crohn's related spondylarthritis but not colitis","volume":"62","author":"Marzo Ortega","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0120","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T lymphocytes from patients with Crohn's disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jbspin.2011.10.001_bib0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1136\/ard.62.6.561","article-title":"Up regulation of the production of tumour necrosis factor alpha and interferon gamma by T cells in ankylosing spondylitis. During treatment with etanercept","volume":"62","author":"Zou","year":"2003","journal-title":"Ann Rheum Dis"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11002326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X11002326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,14]],"date-time":"2024-04-14T19:11:59Z","timestamp":1713121919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X11002326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S1297319X11002326"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2011.10.001","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}